4-Bromo-N-cyclobutyl-3-(trifluoromethyl)benzamide

Catalog No.: 
ACWHZJ779
CAS No.: 
1508181-18-7
Molecular Formula: 
C12H11BrF3NO
Molecular Weight: 
322.12
4-Bromo-N-cyclobutyl-3-(trifluoromethyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$392.00InquiryInquiry
1g98%$1136.00InquiryInquiry
5g98%$2274.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-N-cyclobutyl-3-(trifluoromethyl)benzamide
IUPAC Name4-bromo-N-cyclobutyl-3-(trifluoromethyl)benzamide
MDL No.MFCD25118613
Molecular FormulaC12H11BrF3NO
Molecular Weight322.12
SMILESO=C(NC1CCC1)C2=CC=C(Br)C(C(F)(F)F)=C2
InChI KeyFLUDXBWURPFZKB-UHFFFAOYSA-N
Synonym4-Bromo-N-cyclobutyl-3-(trifluoromethyl)benzamide;Benzamide, 4-bromo-N-cyclobutyl-3-(trifluoromethyl)-
CAS No.1508181-18-7

Synthetic Route by SureRoute

1. ACWHZJ779 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNTA598 route compound structure diagram
    ACCNTA5982516-34-9In Stock
  2. Plus
  3. ACAPQV670 route compound structure diagram
    ACAPQV670161622-14-6In Stock
  4. Then
  5. ACWHZJ779 route product structure diagram
    ACWHZJ7791508181-18-7
Inquiry

2. ACWHZJ779 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNTA598 route compound structure diagram
    ACCNTA5982516-34-9In Stock
  2. Plus
  3. ACTRXO793 route compound structure diagram
    ACTRXO793914636-26-3In Stock
  4. Then
  5. ACWHZJ779 route product structure diagram
    ACWHZJ7791508181-18-7
Inquiry

3. ACWHZJ779 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPBIQ518 route compound structure diagram
    ACPBIQ518107317-58-8In Stock
  2. Plus
  3. ACCNTA598 route compound structure diagram
    ACCNTA5982516-34-9In Stock
  4. Then
  5. ACWHZJ779 route product structure diagram
    ACWHZJ7791508181-18-7
Inquiry

Comments (0)